Sio Gene Therapies Inc
(SIOX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Operating Expenses | 41,523 | 37,907 | 30,587 | 62,554 | 15,142 |
| Operating Income | -41,523 | -37,907 | -30,587 | -62,554 | -15,142 |
| Pre-tax Income | -41,523 | -37,907 | -30,587 | -62,554 | -15,142 |
| Income Tax | 729 | 148 | -917 | 802 | 24 |
| Net Income Continuous | -42,252 | -38,055 | -29,670 | -63,356 | -15,166 |
| Net Income | $-42,252 | $-38,055 | $-29,670 | $-63,356 | $-15,166 |
| EPS Basic Total Ops | -3.44 | -3.04 | -2.48 | -5.12 | -1.20 |
| EPS Basic Continuous Ops | -3.41 | -3.07 | -2.45 | -5.11 | -1.22 |
| EPS Diluted Total Ops | -3.44 | -3.04 | -2.48 | -5.12 | -1.20 |
| EPS Diluted Continuous Ops | -3.41 | -3.07 | -2.45 | -5.11 | -1.22 |
| EBITDA(a) | $-41,512 | $-37,896 | $-30,581 | $-62,560 | $-15,129 |